(Q33442343)

English

The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients (English)

1 reference

Europe PubMed Central

26 July 2017

0 references

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

author name string

Duran C

1

1 reference

Europe PubMed Central

26 July 2017

Tuncel E

2

1 reference

Europe PubMed Central

26 July 2017

Ersoy C

3

1 reference

Europe PubMed Central

26 July 2017

Ercan I

4

1 reference

Europe PubMed Central

26 July 2017

Selimoglu H

5

1 reference

Europe PubMed Central

26 July 2017

Kiyici S

6

1 reference

Europe PubMed Central

26 July 2017

Guclu M

7

1 reference

Europe PubMed Central

26 July 2017

Erturk E

8

1 reference

Europe PubMed Central

26 July 2017

Imamoglu S

9

1 reference

Europe PubMed Central

26 July 2017

publication date

1 January 2009

1 reference

Europe PubMed Central

26 July 2017

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

26 July 2017

32

1 reference

Europe PubMed Central

26 July 2017

1

1 reference

Europe PubMed Central

26 July 2017

69-73

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1007/bf03345682

0 references

Insulin use in NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Combination therapies with insulin in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Comparison of Bedtime NPH or Preprandial Regular Insulin Combined With Glibenclamide in Secondary Sulfonylurea Failure

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Repaglinide/bedtime NPH insulin is comparable to twice-daily NPH insulin

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Acarbose : An Update of its Pharmacology and Therapeutic Use in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: results from a multinational, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

A practical guide to basal and prandial insulin therapy.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Acarbose vs. bedtime NPH insulin in the treatment of secondary failures to sulphonylurea-metformin therapy in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Risk of Hypoglycaemia with Oral Antidiabetic Agents in Patients with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Insulin glargine: a systematic review of a long-acting insulin analogue

1 reference

https://api.crossref.org/works/10.1007%2FBF03345682

21 January 2018

Standards of medical care in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19337019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/19337019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19337019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19337019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin analogues

1 reference

https://pubmed.ncbi.nlm.nih.gov/19337019

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03345682

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33442343&oldid=1647078158"